ALENDRONATE SODIUM
NDC 76282-681, Alendronate sodium, tablet, from EXELAN PHARMACEUTICALS INC..
- Product NDC
- 76282-681
- Status
- Listed
- Labeler
- EXELAN PHARMACEUTICALS INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076768
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76282-681 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALENDRONATE SODIUM35 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76282-681-46 | 76282068146 | 3 BLISTER PACK in 1 CARTON (76282-681-46) / 4 TABLET in 1 BLISTER PACK (76282-681-45) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/91a0f73a-d8cd-4197-b431-40707a2150b9
Use it
Look up 76282-681 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76282-681 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76282-681. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.